Anika Therapeutics Inc. - Common Stock — Cash Flow (NASDAQ:ANIK) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 13.06 M8.4 M4.41 M-1.79 M5.4 M11.19 M 6.47 M Cash from investing activities -71.26 M-3.12 M-7.49 M-5.43 M-8.33 M-401 K -3.31 M Cash from financing activities -3.77 M-6.78 M-4.85 M-6.32 M-12.73 M-10.55 M -15.46 M Free cash flow 13.06 M8.4 M4.41 M-1.79 M5.4 M4.36 M 1.04 M

News

Bullish On Anika Therapeutics’s Pullback As Integrity Scales (NASDAQ:ANIK)

Anika Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ANIK) 2026-04-29

Top 2 Health Care Stocks That May Crash This Quarter - Arcellx (NASDAQ:ACLX), Anika Therapeutics (NASDAQ:ANIK)

Anika Therapeutics, Inc. (ANIK) Presents at 2026 CG Musculoskeletal Conference - Slideshow (NASDAQ:ANIK) 2026-03-02

Anika at 2026 CG Musculoskeletal Conference: Strategic Growth Focus

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika Q4 2025 slides: commercial surge offsets OEM decline

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics names Stephen Griffin as new CEO

Anika Q3 2025 slides: Commercial growth offsets OEM decline

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates